CT News and Research RSS Feed - CT News and Research

Michigan surpasses Medicaid enrollment goal in 4 months

Michigan surpasses Medicaid enrollment goal in 4 months

More people have enrolled in Medicaid's expansion in less than four months than were expected to sign up in the entire first year of the program, the Snyder administration announced Thursday. [More]
Veran announces positive, final results for initial study of SPiNPerc procedure

Veran announces positive, final results for initial study of SPiNPerc procedure

Veran Medical Technologies, a U.S. based medical device company, announced today the positive, cost-effective final results for the initial study of its innovative SPiNPerc procedure. [More]
Mayo Clinic calls for safer pediatric imaging

Mayo Clinic calls for safer pediatric imaging

The benefits of medical imaging far outweigh the risks when children receive The Right Exam, ordered The Right Way, with The Right Radiation Dose. However, overuse and misuse of imaging change the benefit-risk ratio and Mayo Clinic is leading a collaborative effort to ensure a national protocol is put into action. [More]

Those with mental illness face 80% unemployment

But, the report says that while 60 percent of those with mental illnesses want to work, only 2 percent of people in the public mental health system get help to find work. [More]
Aviv acquires two ALFs and one post-acute and long-term care SNF for $82 million

Aviv acquires two ALFs and one post-acute and long-term care SNF for $82 million

Aviv REIT, Inc. announced today it has acquired two assisted living facilities ("ALFs") and one post-acute and long-term care skilled nursing facility ("SNF") for $82.0 million (the "Acquisition"), and two parcels of land and the entitlements for the construction of two new ALFs and a 50 unit addition to one of the existing ALFs for $12.2 million (the "New Construction Projects"), all of which are located in Massachusetts, for a total of $94.2 million. [More]
VA whistleblowers to tell all to House

VA whistleblowers to tell all to House

These whistleblowers say they were often placed on administrative leave for bringing up their concerns. Also, wait times at Connecticut VA clinics explode, even after the recent scandal came to light. [More]
Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study

Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study

Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045). [More]

Review proposes imaging tools to help visualize peripheral nerve regeneration process

Researchers at the Institute of Polymer Science and Engineering in Taipei, Taiwan, led by Dr. Hsu have been involved in peripheral nerve regeneration research for more than ten years. Dr. Hsu and her team have focused on development of polymeric nerve conduits to facilitate peripheral nerve regeneration. [More]
Headbanging to Motörhead thought to have caused bleeding in the brain

Headbanging to Motörhead thought to have caused bleeding in the brain

A recent report in the Lancet describes the case of a man who developed bleeding in the brain after headbanging at a Motörhead concert. [More]

Eligibility for subsidies not properly checked, audit finds

The HHS inspector general issues two reports concluding the federal health marketplace and some state exchanges had inadequate safeguards to stop people who were ineligible from getting tax credits to help pay for premiums. [More]
Justices rule home health care aides can't be forced to pay union dues

Justices rule home health care aides can't be forced to pay union dues

The high court's ruling will make it more difficult for unions in some states to continue organizing the aides, a rapidly growing segment of the workforce. [More]
Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA. [More]
NCCN Policy Summit to address impact of health care reform on academic oncology practice

NCCN Policy Summit to address impact of health care reform on academic oncology practice

On July 10, 2014, the National Comprehensive Cancer Network® (NCCN®) will host the NCCN Policy Summit: The Impact of Health Care Reform on Academic Oncology Practice, at The Westin Arlington Gateway in Arlington, Virginia, as part of the NCCN Oncology Policy Program. [More]
CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis. [More]

Inaccurate doctor lists hurt access for low-income Californians

Meanwhile, confusion over limited providers also has led to unforeseen bills for enrollees in private plans in California, reports The Los Angeles Times. Other stories look at the growing number of insurers who want to participate in the online marketplaces and how 19 states have passed laws restricting the workers who help consumers sign up, despite a new federal rule eliminating many such restrictions. [More]
Genetic variants alter chance of sunitinib dose reduction

Genetic variants alter chance of sunitinib dose reduction

Scientists have identified genetic variants that reduce the likelihood of sunitinib dose reduction in patients with metastatic renal cell carcinoma. [More]
Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. [More]
BRI to present clinical-stage product data at International Symposium on Pediatric Neuro-Oncology

BRI to present clinical-stage product data at International Symposium on Pediatric Neuro-Oncology

The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal®) and Antineoplaston AS2-1 injections (Astugenal®), at the 16th International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014. [More]
Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern. [More]

Bill would bar Medicare advantage plans from dropping doctors mid-year

The proposal, introduced by Democrats in the House and Senate, would require insurers to finalize their doctor networks 60 days before autumn enrollment begins. [More]